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ABSTRACT
Positioned nucleosomes limit the access of proteins
to DNA. However, the impact of nucleosomes
on DNA methylation in vitro and in vivo is poorly
understood. Here, we performed a detailed
analysis of nucleosome binding and nucleosomal
DNA methylation by the de novo methyltransferases.
We show that compared to linker DNA, nucleosomal
DNA is largely devoid of CpG methylation. ATP-
dependent chromatin remodelling frees nucleo-
somal CpG dinucleotides and renders the
remodelled nucleosome a 2-fold better substrate
for Dnmt3a methyltransferase compared to free
DNA. These results reflect the situation in vivo,a s
quantification of nucleosomal DNA methylation
levels in HeLa cells shows a 2-fold decrease of
nucleosomal DNA methylation levels compared to
linker DNA. Our findings suggest that nucleosomal
positions are stably maintained in vivo and nucleo-
somal occupancy is a major determinant of global
DNA methylation patterns in vivo.
INTRODUCTION
In mammals, DNA methylation occurs at CpG sites that
are to 60–80% modiﬁed in a cell-type speciﬁc pattern and
is generally associated with repressed states of chromatin
(1–4). DNA methylation is involved in epigenetic
processes such as differentiation, proliferation, transcrip-
tional regulation, genomic imprinting, X-chromosome
inactivation, silencing of repetitive elements, maintenance
of genomic stability and DNA repair (2,3). Although
some functional overlap exists (5), the DNA methyl-
transferases can be generally divided into two classes:
the ‘maintenance’ DNA methyltransferase Dnmt1 main-
tains methylation patterns on the newly synthesized
daughter strands during replication and the de novo
DNA methyltransferases Dnmt3a and Dnmt3b introduce
novel methylation marks in the genome (6).
The fundamental unit of chromatin is the nucleosome,
composed of 147bp of DNA wrapped around an
octamer of H2A, H2B, H3 and H4 core histone
proteins. Nucleosomes impose a signiﬁcant barrier for
sequence-speciﬁc recognition, impeding the access of regu-
latory proteins to DNA (7). However, chromatin presents
the natural substrate for DNA-dependent processes like
control of gene expression, DNA replication, recombin-
ation and repair (8,9). Therefore active mechanisms like
ATP-dependent chromatin remodelling exist to alter chro-
matin structure in order to regulate DNA accessibility (7).
Chromatin remodelling complexes comprise a highly
diverse group of ATPases belonging to the SNF2 super-
family that have the capability to slide, evict or destabilize
nucleosomes (10,11). The ATPases are present in a large
number of different multiprotein complexes with
specialized functions regarding the organization of chro-
matin and the regulation of DNA-dependent processes
(11,12).
Chromatin remodelling enzymes also impact cellular
DNA methylation. Deletion of the remodelling ATPase
DDM1 in Arabidopsis or its murine homolog Lsh results
in a global loss of DNA methylation (13,14). Lsh was
shown to recruit de novo DNA methyltransferases (15)
and to cooperate with Dnmt3b in PRC and HDAC-
mediated gene silencing (16,17). Mutations in the ATRX
gene, belonging to the Rad54 subfamily (Snf2 family) (10)
result in the ATR-X syndrome that is characterized by
both hypo- and hypermethylation of rDNA repeats (18).
Furthermore, the hSnf2H containing complex NoRC
(19) represses rDNA transcription by recruiting DNA
methyltransferase and histone deacetylase (20). Direct
interaction of Dnmt1 with hSnf2H increased the afﬁnity
of Dnmt1 towards nucleosomes (21) and the de novo DNA
methyltransferases Dnmt3a and Dnmt3b were found in
complexes with Brg1 (22) and hSnf2H, respectively (23).
But still, the question remains whether genomic DNA is
globally rendered accessible by the ATP converting
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restricted and therefore chromatin structure determines
DNA methylation patterns.
The enzymatic properties of the DNA methyl-
transferases have been extensively studied on free DNA
as substrate (24–29). However, functional studies on DNA
methylation in chromatin are very limited and the results
are not consistent. Nucleosomal DNA methylation was
either shown not to be affected by Dnmt1 and Dnmt3a
irrespective of the DNA sequence (30), to be signiﬁcantly
reduced for Dnmt1, Dnmt3a and Dnmt3b (21,31,32), or
to be inhibited for Dnmt3a (33).
To evaluate the effect of positioned nucleosomes on
the DNA methylation efﬁciency in vitro and in vivo,w e
performed high-resolution mapping of de novo DNA
methylation events in reconstituted chromatin systems
and quantiﬁed nucleosomal DNA methylation in vivo.
MATERIALS AND METHODS
Plasmids
Human Dnmt3a was PCR-ampliﬁed from
IRATp970A0473D (RZPD), cut with BamHI/EcoRI
and cloned into pENTR3C (Invitrogen) following
LR-recombination into pDEST10 (Invitrogen). Human
Dnmt3b2 (kind gift from F. Lyko) was PCR-ampliﬁed,
cut with BamHI/NheI and cloned into a modiﬁed
pET11 bacterial expression vector (Novagen) carrying an
N-terminal Flag-tag and a C-terminal 6  His-tag
(pETM). Sequences were veriﬁed by sequencing. Snf2H
K211R point mutant [kindly provided by R.
Shiekahattar (34)] was cloned with a C-terminal Flag-tag
in pFastbac1 (Invitrogen). The plasmids pPCRScript_
slo1-gla75, pGA4 BN601-m1, pMA BN601mod
rDH70_Cless were used for PCR ampliﬁcation of DNA
fragments for chromatin reconstitution.
Protein puriﬁcation
Induction of Dnmt3b2 expression (pETM-Dnmt3b2
N-Flag, C-His) in BL21 Escherichia coli cells was carried
out at an OD600 of 0.5–0.6 with 1.0mM IPTG for 3h
at 24 C.
Baculovirus carrying N-His Dnmt3a (pDEST10-
Dnmt3a) or C-Flag Snf2H K211R were prepared as
described (Invitrogen, Bac-to-Bac). The baculovirus for
C-Flag Snf2H expression was generously provided by
R. Kingston (35). 2.0 10
8 Sf21 insect cells were
infected for 48–60h and cells stored at  80 C until use.
All puriﬁcation steps were performed on ice. Protease
inhibitors PMSF (1.0mM), Leupeptin (1–10mg/ml),
Aprotinin, Pepstatin (1.0mg/ml) were added to buffers
prior to use.
Preparing cell lysates
Sf21 insect cells (2.0–2.5 10
8) resuspended in 10ml lysis
buffer were lysed by three repeated freeze-thaw cycles and
subsequently treated with ﬁve strokes each of A-type and
B-type pestle in a dounce homogenizer. Cells were further
treated by soniﬁcation with a Branson Soniﬁer 250D
(3  for 30s 50% amplitude, 50% duty cycle) following
clearance by centrifugation (30min, 20000g,4  C).
Escherichia coli cells were resuspended in lysis buffer
(10ml/1.0g cells) supplemented with lysozyme (1.0mg/
1.0ml lysate) following incubation for 30min at 4 C.
Cells were treated with ﬁve strokes of a B-type dounce
homogenizer and soniﬁed following clearance by
centrifugation.
Puriﬁcation of C-Flag Snf2H
Sf21 cell lysate was prepared in EX-500 buffer (500mM
KCl, 20mM Tris buffer pH 7.6, 10% glycerol, 1.5mM
MgCl2, 0.5mM EGTA) supplemented with 0.1% NP-40.
The cleared lysate was incubated with 200ml M2-afﬁnity
gel (Sigma) for 2h at 4 C After washing (3  with lysis
buffer) proteins were eluted with one bed volume of buffer
EX-300 supplemented with 0.05% NP-40 and Flag
peptide (400ng/ml). Eluted proteins were directly snap
frozen in liquid nitrogen and stored at  80 C.
Puriﬁcation of Dnmt3a and Dnmt3b2
Prior to use all buffers were supplemented with 5mM
ß-mercaptoethanol. Dnmt3a/Dnmt3b2 cell lysates were
prepared in lysis buffer (20mM Tris, pH 7.5;
10% glycerol; 500mM NaCl; 0.5% NP-40; 5.0mM
imidazole) and incubated with Ni-NTA agarose
(Qiagen). ‘Beads’ were washed once with ﬁve bead
volumes of lysis buffer and three times with wash buffer
1 (20mM Tris pH 7.5; 10% glycerol; 500mM NaCl,
40mM imidazole, 0,1% NP-40). Dnmt3a was in
addition washed twice with wash buffer 2 (20mM Tris
7.5; 10% glycerol; 10mM NaCl, 0.1% NP-40). Bound
proteins were batch-eluted with the addition of elution
buffer (D3a: 20mM Tris, pH 7.5; 10% glycerol; 10mM
NaCl; 1000mM imidazole, 2.0mM EDTA, 0.1% NP-40;
D3b2: 20mM Tris, pH 7.5; 10% glycerol; 250mM NaCl;
250mM imidazole, 2.0mM EDTA, 0.1% NP-40). Elution
fractions were combined, dialyzed against buffer SP-200
(200mM NaCl, 20mM Tris, 7.5, 2.0mM MgCl2, 1.0mM
EDTA, 10% glycerol, 0.05% NP-40) and loaded onto a
SP FF column (GE Healthcare). Dnmt3a and Dnmt3b2
were step-eluted with SP-400 and SP-500 buffer, respect-
ively. Peak fractions were combined, dialyzed against
SP-200 buffer and snap frozen in small aliquots in liquid
nitrogen and stored at  80 C.
Nucleosome reconstitution by salt gradient dialysis
Chromatin assembly of DNA fragments with histone
octamers from drosophila using the salt dialysis technique
was performed as previously described (36) A typical
assembly reaction (50ml) contained 5.0mg DNA, varying
amounts of histone octamer, 200ng BSA/ml, and 250ng
competitor DNA in high salt buffer (10mM Tris, pH 7.6,
2.0M NaCl, 1.0mM EDTA, 0.05% NP-40, 2.0mM
ß-mercaptoethanol). The salt was continuously reduced
to 200mM NaCl during 16–20h. The quality of the
Nucleic Acids Research, 2011,Vol.39, No. 16 6957assembly reaction was analysed on a 5.0% PAA in
0.4  TBE following ethidium bromide staining.
Nucleosome mobility assay
Nucleosome remodelling reactions were performed as
described (12). Brieﬂy, reaction mixes in RB90 buffer
(20mM Tris, pH 7.6, 1.5mM MgCl2, 1.0mM EDTA,
10% glycerol, 90mM KCl, 1.0mM DTT) supplemented
with 1.0mM ATP and 200ng BSA/ml containing 200ng
(1.0 picomol) reconstituted L78-NPS2-L79 and 50–200ng
(0.5–2.0 picomol) Snf2H were incubated for 90min at
26 C. Remodelling reactions were stopped by the
addition of 50–100ng competitor DNA (pCpGL-basic,
0.25–0.5 femtomol) and nucleosome positions were
analysed by native PAGE. The non-hydrolysable ATPgS
and the mutant Snf2H K211R were used as substitutes
for ATP and WT Snf2H, respectively.
Electromobility shift assay
Electromobility shift assays (EMSAs) with Dnmt3a and
Dnmt3b2 were performed in 20ml reaction volume in
20mM Tris, pH 7.6, 30mM KCl, 5.0mM EDTA,
1.0mM DTT, 5.0mM SAM, 20% glycerol. Reconstituted
nucleosomes were incubated with Dnmt3a/b2 for 15min
at 26 C to allow for complex formation. Reactions were
put on ice, loaded onto a 5.0% PAA gel in 0.4  TBE
and the DNA was visualized by ethidium bromide
staining.
Isolation of endogenous nucleosomal DNA by MNase
digest
Digestion of chromatin from Hela cells (2 10
7) was
performed with microccal nuclease (MNase Sigma;
100–1000U) in 3.0ml permeabilization buffer (15mM
Tris, pH 7.6, 300mM sucrose, 60mM KCl, 15mM
NaCl, 4.0mM CaCl2, 0.5mM EGTA, 0.2% NP-40,
0.5mM ß-mercaptoethanol) for 3min at 37 C. The
nuclease reaction was stopped by addition of 3.0ml stop
buffer (50mM Tris, pH 8.0, 20mM EDTA, 1.0% SDS).
RNA was degraded with 250mg RNAse A for 2h at 37 C
and cellular proteins digested with 250mg proteinase K at
37 C overnight. Nucleosomal DNA recovered after
ethanol precipitation was subjected to separation on
1.5% agarose gels in 1  TBE. Clearly separated 1n, 2n,
3n nucleosomal DNAs were excised from the gel and
DNA was eluted using the BioRAD Electro-Eluter
according to the manufacturer’s protocol. Purity of
nucleosomal DNA preparations was analysed by agarose
gel electrophoresis.
Micellar capillary electrophoresis
Sample preparation of mononucleosomal and HeLa
genomic DNA was adapted from the protocol established
by Fraga (37). Brieﬂy, DNA Samples (10ml,  2mg/ml)
were heated for 5min at 95 C and cooled on ice. After
addition of 4ml Milli-Q grade H2O, 1ml 10mM ZnSO4
and 2ml P1 nuclease (Sigma-Aldrich, reconstituted to
250U/ml in 30mM sodium acetate), samples were
digested over night at 37 C. Dephosporylation was
performed by the addition of 2ml of 500U/ml antarctic
phosphatase (NEB, in 50mM Tris–HCl pH 7.6, 5mM
MgCl2) for 2h at 37 C. For CE analysis samples were
concentrated by lyophilization and redissolving the
samples in 4–10ml Milli-Q grade H2O.
Micellar capillary electrophoresis of nucleosides was
adapted from Fraga (37) to our PA800 ProteomeLab
capillary electrophoresis system (Beckman-Coulter).
Samples were injected by negative pressure 1.38kPa
(0.2psi) for 10s into an uncoated fused-silica capillary
(100mm ID, 67cm total length, 57cm effective length,
Beckman Coulter) in running buffer (48mM NaHCO3,
pH 9.6; 60mM SDS). Separation was performed at
17kV (electrical ﬁeld strength 254V/cm) for 13min and
UV absorption was monitored at 254nm. Before and in
between runs the capillary was rinsed with 1.0M NaOH
for 1min, 1.0mM NaOH for 2min and running buffer
for 3min. Prior to the experiments the capillary was
rinsed as described above and equilibrated at 17kV
for 1.0h. We found that this signiﬁcantly increased repro-
ducibility. For reference, nucleosides 20-deoxyadenosine
(A), 20-deoxythymidine (T), 20-deoxyguanosine (G),
20-deoxycytidine (C) (Sigma-Aldrich) and 5-methyl
20-deoxycytidine (5-meC; Biomol GmbH) were dissolved
at 5.0mM in Milli-Q grade H2O.
We calculated the 5-meC content as percentage of the
area 5-meC/area C+area 5-meC and found a 5-meC level
for HeLa genomic DNA of 3.06% (±0.17%) (Figure 4D)
consistent with previous ﬁndings (37). The 5-meC content
of linker DNA was calculated as the difference of the
5-meC content (HeLa gDNA) and the 5-meC content
(1n). The relative 5-meC content of linker and nucleosom-
al DNA was determined considering an average nucleo-
somal repeat length of 188bp in HeLa cells (38) and a
nucleosome length of 147bp. The total of methylated
CpG sites was calculated as the percentage of the propor-
tion of linker DNA added to the proportion of nucleo-
somal DNA multiplied with the relative nucleosomal
5-meC content.
In vitro DNA methyltransferase assay for Dnmt3a and
Dnmt3b2
Typical de novo DNA methyltransferase reaction (50ml)
contained 100nM Dnmt3a and Dnmt3b2, DNA
template and oligonucleotides at 500 and 5000nM CpG
sites, respectively, 200ng BSA/ml and 480nM
3H-SAM
(GE Healthcare, TRK581-250UCi, 9.25 MBq with
1.0mCi/ml and 63.0Ci/mmol) in DNA methyltransferase
buffer (20mM Tris, pH 7.6, 1.0mM EDTA, 1.0mM
DTT). The reaction was started with the addition of
DNA, incubated at 37 C for 10–30min, and stopped
with 10ml of 10mM SAM (Sigma). The reaction was
spotted on DE81 ﬁlter (Whatman), washed three times
with 0.2M NH3HCO3, once with water and ethanol
following drying and scintillation counting.
DNA methylation mixtures (25ml) added to nucleosome
mobility reactions (25ml), contained 200nM Dnmt3a/b2,
6958 Nucleic Acids Research, 2011,Vol.39, No. 16200ng BSA/ml, 960nM
3H-SAM in 40mM Tris, pH 7.6,
4.0mM EDTA, 2.0mM DTT.
Bisulﬁte conversion and analysis of CpG site methylation
Site-speciﬁc DNA methylation analysis was performed
with the C91-NPS2-C104 DNA fragment (342bp,
27 CpG sites) as free DNA or fully reconstituted
mononucleosome. DNA methylation reactions (40ml)
with 600nM Dnmt3a or 200nM Dnmt3b2 were carried
out in DNA methyltransferase buffer (20mM Tris, pH
7.6, 1.0mM EDTA, 1.0mM DTT) with 200ng BSA/ml,
250mM SAM (SIGMA) and template at 1800 and
20nM CpG sites, respectively. Reactions with M.SssI con-
tained 4U of enzyme and 20nM CpG sites in 1  NEB
buffer 2. The reactions were incubated for 4h at 37 C
following heat-inactivation at 65 C for 20min. DNA
methylation reactions were processed according to the
Epitect bisulﬁte conversion kit (Qiagen). The upper (+)
and the lower strand ( ) of the bisulﬁte-converted DNA
were PCR-ampliﬁed with primer pairs MF81/82 and
MF112/113.
PCR fragments were cloned into the pGEM-T-EASY
vector (Promega) according to the manufacturer’s instruc-
tions, and the DNA from positive clones was sent for
sequencing. Analysis and quality control of bisulﬁte-
converted DNA was done with BiQ ANALYZER
software (http://biq-analyzer.bioinf.mpi-inf.mpg.de/)
provided by C. Bock (39). The DNA methylation fre-
quency of each CpG site was plotted against the respective
CpG dinucleotides of the DNA sequence.
D3A DNA (+) 32 clones, D3A DNA ( ) 39 clones,
D3A nuc (+) 29 clones, D3A nuc ( ) 44 clones, D3b2
DNA (+) 31clones, D3b2 DNA ( ) 37 clones, D3b2 nuc
(+) 25 clones, D3b2nuc ( ) 22 clones, M.SssI DNA (+) 22
clones, M.SssI DNA ( ) 23 clones, M.SssI nuc (+) 19
clones, M.SssI nuc ( ) 21 clones.
DNA fragments
DNA fragments containing a modiﬁed nucleosome
positioning sequence 601 (40) (referred to as NPS1,
147bp, 3 CpG sites) are ﬂanked by a partial rDNA
promoter sequence ( 80bp) on the left and a partial
HSP70 promoter sequence ( 85bp) on the right. By
using different combinations of oligonucleotides, symmet-
rical and asymmetrical linker DNA of variable length,
relative to the NPS sequence, can be generated.
In addition, two other DNA fragments were designed
for DNA methylation studies. Both carry a CpG site sup-
plemented modiﬁed 601 nucleosome positioning sequence
(15 CpG sites, referred to NPS2), but differ in their CpG
content of their ﬂanking DNA overhangs. For DNA
methylation studies, either new CpG sites were introduced
into the linker DNA (referred to as ‘C’ precedent to the
number for the linker length) or completely mutated
(referred to as non-CpG ‘N’).
The DNA fragments were ampliﬁed by PCR and
puriﬁed DNA fragments were subsequently used for
nucleosome assembly reactions. Due to oligonucleotide
annealing the NPS1 used consists of 142bp instead of
147bp.
Template Primer
(forward)
Primer
(reverse)
DNA template length
NPS1 AP7 AP8 pPCRScript_slo1-gla75 142
22-NPS1 AP3 AP8 pPCRScript_slo1-gla75 164
22-NPS1-22 AP3 AP13 pPCRScript_slo1-gla75 191
40-NPS1 AP5 AP8 pPCRScript_slo1-gla75 182
40-NPS1-40 AP5 AP14 pPCRScript_slo1-gla75 227
77-NPS1 AP1 AP8 pPCRScript_slo1-gla75 219
77-NPS1-77 AP1 AP15 pPCRScript_slo1-gla75 301
NPS2 MF124 MF125 pGA4 BN601-m1 150
C91-NPS2-
C104
MF79 MF80 pGA4 BN601-m1 342
N78-NPS2-
N79
MF133 MF134 pMA BN601mod
rDH70_Cless
304
DNA sequences
NPS2 (150bp, 15 CpG sites)
GATCCCGAATCCCGGTGCCGAGGCCGCTCAATT
GGTCGTAGCAACGTCTAGCACCGCTTAAACGCA
CGTACGCGCTGTCCCCCGCGTTTTAACCGCCAA
GGGGATTACTCCCTAGTCTCCAGGCACGTGTCA
GATATATACAGCTAG
C91-NPS2-C104 (342bp, 27 CpG sites)
GAATTGGGTACCAGATCTTTTGAGGTCCGGTTC
TTTTCGTTATGGGGTCATATGTTTCGGCCACCTC
CCCATGGTACGACTTCCAGGTACGGATCCCGAA
TCCCGGTGCCGAGGCCGCTCAATTGGTCGTAGC
AACGTCTAGCACCGCTTAAACGCACGTACGCGC
TGTCCCCCGCGTTTTAACCGCCAAGGGGATTAC
TCCCTAGTCTCCAGGCACGTGTCAGATATATAC
AGCTAGCGACAAAGAAAACTCGAGAAATTTCTC
GTAAGGCCGTTATTCTCTAGATTCGTTTTGTGA
CGCTCCCTCTCCGTACTAAGATCTGAGCTCCAG
CTTTTGTTCCC
N78-NPS2-N89 (304bp, 15 CpG sites)
TCTTTTGAGGTTGGGTTCTTTTGCTTATGGGGT
CATATGTTTGGGCCACCTCCCCATGGTATGACT
TCCAGGTATGGATCCCGAATCCCGGTGCCGAG
GCCGCTCAATTGGTCGTAGCAACGTCTAGCACC
GCTTAAACGCACGTACGCGCTGTCCCCCGCGTT
TTAACCGCCAAGGGGATTACTCCCTAGTCTCCA
GGCACGTGTCAGATATATACAGCTAGCTATGAA
AGAAAACTGCAGAAATTTCTCTTAAGGCAGTTA
TTCTCTAGATTGCTTTTGTGACTCTCCCTCTCTG
TACTAAG
NPS1 (142bp, 3 CpG sites)
GATCCAGAATCCTGGTGCTGAGGCTGCTCAATT
GGTTGTAGCAAGCTCTAGCACTGCTTAAATGCA
TGTACGCGCGGTCCCCTGTGTTTTAACTGCCAA
GGGGATTACTCCCTAGTCTCCAGGCATGTGTCA
GATATATACA
77-NPS1-77 (301bp, 9 CpG sites)
ATCTTTTGAGGTCCGGTTCTTTTCGTTATGGGG
TCATATGTTTGGGCCACCTCCCCATGGTATGAC
TTCCAGGTATGGATCCAGAATCCTGGTGCTGAG
GCTGCTCAATTGGTTGTAGCAAGCTCTAGCACT
Nucleic Acids Research, 2011,Vol.39, No. 16 6959GCTTAAATGCATGTACGCGCGGTCCCCTGTGTT
TTAACTGCCAAGGGGATTACTCCCTAGTCTCCA
GGCATGTGTCAGATATATACAGCTAGCTAGCAA
AGAAAACTCGAGAAATTTCTCTTAAGGCCGTTA
TTCTCTAGATTCGTTTTGTGACTCTCCCTCTCTG
TAC
Oligonucleotides
Name Sequence 50–30
AP1 ATCTTTTGAGGTCCGGTTCTTT
AP3 CATGGTATGACTTCCAGGTATGG
AP5 ATGTTTGGGCCACCTCCCC
AP7 GATCCAGAATCCTGGTGCTGAG
AP8 TGTATATATCTGACACATGCCTGGA
AP13 TTTCTCGAGTTTTCTTTGCTAGCT
AP14 TAACGGCCTTAAGAGAAATTTCT
AP15 GTACAGAGAGGGAGAGTCACAAAAC
MF79 GAATTGGGTACCAGATCTTTTGAG
MF80 GGGAACAAAAGCTGGAGCTC
MF81 GAATTGGGTATTAGATTTTTTGAGGTT
MF82 AAAAACAAAAACTAAAACTCAAATCTTAATA
MF112 GGGAATAAAAGTTGGAGTTTAGATTTTA
MF113 AAATTAAATACCAAATCTTTTAAAATCC
MF124 GATCCCGAATCCCGGTG
MF125 CTAGCTGTATATATCTGACACGTGCC
MF133 TCTTTTGAGGTTGGGTTCTTTTG
MF134 CTTAGTACAGAGAGGGAGAGTCACAA
RESULTS
Dnmt3a and Dnmt3b2 have distinct nucleosome binding
properties
In order to characterize the nucleosomal binding mode
of the de novo methyltransferases, human Dnmt3a and
Dnmt3b2 proteins were puriﬁed via their 6  His-tag
from Sf21 and E. coli cells, respectively (Figure 1A).
Importantly, a second puriﬁcation step was included,
involving a cation exchange matrix (SP FF, GE
Healthcare), to remove associated DNA still present
after afﬁnity puriﬁcation (Figure 1B, lanes 1–4). This is
a critical puriﬁcation step, avoiding unspeciﬁc methylation
of the co-puriﬁed DNA, a potential problem in the
interpretation of the results of previous studies (21,30).
Deﬁned nucleosomal substrates with a single positioned
nucleosome were reconstituted on DNA fragments
containing a strong nucleosome positioning sequence at
varying positions on the DNA (Figure 1C). We used a
variant of the 601 nucleosome positioning sequence (40)
(referred to as NPS1) that was extended at only one side
(asymmetric nucleosomes containing only one linker) or at
both sides (symmetric nucleosomes with two DNA
linkers) with DNA linkers of varying length. DNA frag-
ments were generated by PCR and reconstituted into
nucleosomes by the salt dialysis method. Binding studies
with increasing concentrations of Dnmt3a and Dnmt3b2
were performed using a mixture of free DNA and
nucleosomes in competitive EMSAs (Figure 1D and
Supplementary Figure S2).
Using the nucleosomal substrates 77-NPS1-77,
77-NPS1, NPS1 and the corresponding free DNA,
Dnmt3a preferentially bound the symmetric 77-NPS1-77
nucleosome whereas the other substrates were bound with
lower afﬁnity (Figure 1D, lanes 1–4). Dnmt3a did prefer-
entially bind to symmetric nucleosomes with longer linker
DNA over symmetric and asymmetric nucleosomes
with shorter linker DNA and free DNA (Supplementary
Figure S2A and B, lanes 1–4). This pattern of binding
suggests that Dnmt3a recognizes nucleosomal structures
in addition to free DNA, resulting in a higher afﬁnity
towards nucleosomal DNA than to free DNA.
In contrast, Dnmt3b2 bound with similar afﬁnity to
free DNA and the 77-NPS1-77 nucleosome and with
decreasing afﬁnity to the 77-NPS1 nucleosome and
the asymmetric and symmetric nucleosomes with even
shorter DNA linkers (Figure 1D, lanes 5–8 and
Supplementary Figure S2A and B, lanes 5–8). The data
suggest a different binding mode for Dnmt3b2 compared
to Dnmt3a in that Dnmt3b2 mainly recognizes free DNA
and does not speciﬁcally recognize nucleosomal structures.
De novo methylation of nucleosomal DNA is strongly
inhibited
To evaluate the extent of de novo DNA methylation of
nucleosomes, three different templates with a modiﬁed
601 sequence (NPS2) containing additional CpG sites
were reconstituted into chromatin. CpG sites were
placed such that potential methylation sites were spread
along the whole nucleosome positioning sequence.
Nucleosomes were reconstituted either on DNA fragments
containing DNA linkers with CpG sites or lacking
DNA methylation sites. In contrast to the EMSAs,
histone:DNA ratios were titrated such that DNA was
completely reconstituted into mononucleosomes (Figure
2A). Nucleosomes were almost exclusively positioned on
the NPS2 sequence as visualized by the discrete
mononucleosomal band on the native polyacrylamide gel
and as veriﬁed by a restriction enzyme accessibility assay
(Supplementary Figure S3A and B).
De novo DNA methylation reactions were performed
with each template either as free DNA or reconstituted
into mononucleosomes (Figure 2, Supplementary
Figure S4). The bacterial CpG-speciﬁc DNA methyl-
transferase M.SssI served as control for free DNA
contaminations and to detect accessible CpG sites as it
was shown not to methylate within nucleosomes
(30,31,41). In addition we used M.SssI to normalize our
methylation reactions and to reveal functional differences
between the de novo methyltransferases.
Dnmt3a and Dnmt3b2-dependent DNA methylation
efﬁciency of the C91-NPS2-C104 fragment (containing
CpGs in the linker), was similar on free and nucleosomal
DNA (Figure 2B), yielding a DNA:NUC methylation
ratio of  1.3 (Figure 2C, Supplementary Figure S4).
Since the DNA methylation reactions are not endpoint
reactions (Supplementary Figure S4), efﬁcient methylation
of the linker DNA is observed and similar methylation
efﬁciencies were expected for the free DNA and nucleo-
somal DNA. In contrast, methylation of the linker-less
NPS2 nucleosome was repressed by a factor of 36 and
27 for Dnmt3a and Dnmt3b2, respectively (Figure 2B
and C, Supplementary Figure S4), indicating that only
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methylated CpG dinucleotide within the nucleosomal
region. This result clearly shows a strong reduction of
DNA methylation towards nucleosomes, and indicates
that DNA wrapped around the histone octamer represents
a major obstacle to de novo DNA methylation in vitro.
As we have shown above, Dnmt3a and Dnmt3b2 bind
efﬁciently to symmetric nucleosomes with long DNA
linkers. Therefore, we analysed the N78-NPS2-N79
nucleosome, an optimal substrate for both de novo
methyltransferases, lacking CpG sites in the DNA linker
(Figure 2A). Dnmt3a- and Dnmt3b2-mediated nucleo-
somal DNA methylation was repressed on this template
by 6.8- and 4.5-fold, respectively (Figure 2B and C).
Repression was signiﬁcantly lower as for the linker-free
NPS2 nucleosome. However, also the M.SssI-dependent
repression was reduced to 16.1-fold for this template,
showing that the substrate still maintained accessible
CpG sites (Figure 2B and C). Compared to M.SssI, the
mammalian enzymes exhibited 2- to 4-fold higher
nucleosomal methylation activities, suggesting a low
level of nucleosomal DNA methylation. However, this
assay does not allow to quantify and to identify the sites
of nucleosomal DNA methylation.
De novo methylation occurs at the borders of the
nucleosomes
To reveal the extent of nucleosomal DNA methylation we
conducted a detailed site-speciﬁc CpG methylation
analysis of free and nucleosomal C91-NPS2-C104 with
Dnmt3a, Dnmt3b2 and M.SssI using bisulﬁte conversion
(Figure 3). After stopping the DNA methylation reaction,
the puriﬁed DNA was treated with bisulﬁte, resulting in
the deamination of the non-methylated cytosine residues
to uracil. DNA templates were ampliﬁed by PCR, cloned
and the DNA methylation pattern was subsequently
analysed by sequencing of individual clones. In contrast
to the incorporation of
3H- or
14C-labelled methyl-groups,
following scintillation counting or PAGE-based quantiﬁ-
cation, respectively, this technique allows a quantitative
and qualitative evaluation of DNA methylation events
on the (+) and ( ) DNA strand at the same time.
As expected, the bacterial DNA methyltransferase
M.SssI efﬁciently methylated all CpG sites on both the
(+) and the ( ) strand of the free DNA (Figure 3A,
light grey) and only the protein free DNA of the nucleo-
somal template (Figure 3A, dark grey). Visual inspection
and the calculated DNA:NUC methylation ratio of
Figure 1. Dnmt3a and Dnmt3b2 have distinct substrate binding properties. (A) His-tagged Dnmt3a and Dnmt3b2 were puriﬁed using Ni-NTA
columns (lanes 1 and 3), followed by cation exchange chromatography (SP-Sepharose; lanes 2 and 4). Proteins were subjected to SDS–PAGE and
Coomassie Blue staining. Sizes of the molecular weight marker are indicated. (B) Dnmt3a and Dnmt3b2 (His Dnmt; lanes 1 and 2) isolated only by
His-tag-afﬁnity puriﬁcation, or by His-tag- and subsequent cation exchange puriﬁcation (SP Dnmt; lanes 3 and 4) were analysed for co-purifying
DNA contaminations. Five micrograms of each protein preparation was incubated with RNaseA and proteinaseK. The remaining DNA was puriﬁed
and analysed by agarose gel electrophoresis and staining with ethidium bromide. Molecular weight marker (M) and sizes are indicated. (C) DNA
fragments containing the NPS1 sequence located either in the centre of the DNA or close to the DNA border were partially assembled into
mononucleosomes using the salt dialysis method. The sizes of the linker DNA next to the NPS1 sequences are indicated. (D) Different nucleosomal
templates were mixed in 1:1 ratio (lanes 1 and 5) and incubated with a 3.5- to 15-fold molar excess of Dnmt3a and Dnmt3b2 (lanes 2–4 and 6–8).
Reactions were analysed by native polyacrylamide gel electrophoresis next to a molecular weight marker (M).
Nucleic Acids Research, 2011,Vol.39, No. 16 6961160 clearly shows a perfect nucleosomal substrate,
omitting free DNA and having all nucleosomes perfectly
positioned on the NPS2 sequence. The overall DNA
methylation efﬁciency of Dnmt3a and Dnm3b2 towards
free DNA was reduced compared to M.SssI (Figure 3A),
however our enzymes exhibited a 2- to 3-fold higher
methylation efﬁciency compared to enzymes prepar-
ations used in previous studies (42). The different
de novo DNA methylation patterns of Dnmt3a and
Dnmt3b2 on free DNA may be contributed to sequence
preferences (43) or distributive and processive DNA
methylation mechanisms of the enzymes (28) (Figure 3A,
light grey).
Visual inspection clearly shows that the accessible linker
DNA is efﬁciently methylated by Dnmt3a and Dnmt3b2
and that the nucleosomal DNA is refractory to DNA
methylation. If nucleosomal DNA methylation events
are observed, they are located at CpG sites close to the
entry/exit sites of the nucleosomes and are not distributed
along the entire nucleosome (Figure 3A). Comparing the
Figure 2. Nucleosomes are major obstacles for de novo DNA methylation in vitro. (A) DNA templates containing the NPS2 sequence either with
linker DNA containing CpG sites (C91-NPS2-C104, 12 CpG sites in linker, lanes 1 and 2), without linker DNA (NPS2, 15 CpG sites, lanes 3 and 4)
or with linker DNA depleted of CpG sites (N78-NPS2-N79, lanes 5 and 6) were fully reconstituted into mononucleosomes. Nucleosomes were
analysed by native PAGE next to a molecular weight marker (M). Black triangles (ﬁlled inverted triangle) indicate CpG sites. (B) Free DNA and
nucleosomes described in (A) were subjected to in vitro DNA methylation reactions with the indicated DNA methyltransferases. The incorporation of
the
3H-methyl was quantiﬁed and the methylation efﬁciency (given as percentage relative to free DNA) is plotted. Black triangles indicate CpG sites
and the oval indicates the position of the nucleosome. (C) The ratios of the methylation efﬁciencies of DNA compared to nucleosomes (DNA/NUC)
are given for the indicated nucleosomal templates. Black triangles indicate CpG sites and the oval indicates the position of the nucleosome.
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suggest that the latter have a low nucleosomal DNA
methylation activity.
The radioactive DNA methylation assay perfectly
matches the bisulﬁte analysis as revealed by the quantita-
tive evaluation of the nucleosomal DNA methylation.
Calculations of the DNA:NUC ratios of DNA methyla-
tion from the bisulﬁte-treated sequences and the
radioactive assay using the NPS2 DNA fragment give
rise to ratios between 27 and 35 (Figure 3B). This corres-
ponds to 2.8–.7% of nucleosomal DNA methylation by
the de novo methyltransferases. Hence, the observed
reduction of nucleosomal DNA methylation (Figure 2B,
NPS2) was not due to different Dnmt/nucleosome binding
afﬁnities (Figure 1C, Supplementary Figure S2) but due
to the inaccessibility of CpG sites.
Figure 3. De novo DNA methylation is limited to the entry/exit sites of the nucleosome. (A) DNA methylation reactions of the de novo DNA
methyltransferases and M.SssI with the free DNA or the nucleosomal DNA fragment C91-NPS2-C104 were subjected to bisulﬁte conversion.
The methylation frequency for each CpG site is plotted against the CpG sites of the DNA sequence. Analysis of the free DNA (light grey) and
the nucleosomal template (dark grey) for the (+) strand and the ( ) strand is shown. The position of the nucleosome is indicated. On average 20–40
sequences for each strand were sequenced. (B) The ratio of methylation events within the NPS2 sequence (black box, ﬁlled inverted triangle arrows
indicated CpG sites) of DNA and nucleosomes as an average of the (+) and the ( ) strand was calculated for C91-NPS2-C104 from the bisulﬁte
experiments, and for NPS2 from the radioactive assay. The DNA/NUC ratios are indicated in the ﬁgure.
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Dnmt3a
Next we addressed whether ATP-dependent nucleosome
remodelling has an effect on DNA methylation.
We reconstituted nucleosomes on the N78-NPS2-N79
DNA, placing the nucleosome on the CpG containing
center of the DNA fragment (Supplementary Figure
S6A). Snf2H repositions this nucleosome in the presence
of ATP to a site close to the DNA end, thereby exposing
the majority of CpG sites (Figure 4A, Supplementary
Figure S6B–D). Nucleosome remodelling in the presence
of non-hydrolysable ATPgS and the ATPase mutant
Snf2H K211R served as controls (Figure 4A,
Supplementary Figure S1).
Nucleosome remodelling reactions were supplemented
with either M.SssI or the de novo DNA methyltransferases
and incubated for 10 and 30min with
3H-SAM.
Radioactive signals were quantiﬁed and normalized to
the methyltransferase activity on free DNA (Figure 4B).
M.SssI was severely inhibited by the nucleosomal template
demonstrating the high quality of the positioned nucleo-
some. However, it has to be mentioned that repression was
not as efﬁcient as shown in Figure 2, as the nucleosomal
batch contained slightly elevated levels of free DNA.
Active remodelling by the addition of Snf2H and ATP
results in the efﬁcient relocation of the nucleosome to
the border of the DNA fragment (Figure 4A, lane 4).
However, only  50% of the CpG sites were rendered
accessible as monitored by M.SssI methylation
(Figure 4B, lane 6).
Due to the nucleosomal DNA methylation activity of
the de novo methyltransferases, nucleosomal methylation
was less reduced as compared to M.SssI (Figure 4B).
However, active chromatin remodelling resulted in a
DNA methylation activity comparable to free DNA in
the case of Dnmt3b2 (Figure 4B, lane 12). Nucleosomal
methylation activity of Dnmt3a was inhibited like for
Dnmt3b2, but the enzymes behaved differently on the
remodelled substrate. Unexpectedly, the DNA methyla-
tion efﬁciency of Dnmt3a for the remodelled nucleosome
was almost twice as high as for the free DNA (Figure 4B,
lane 18), suggesting that Dnmt3a does preferentially
recognize the remodelled substrate. The increase in
DNA methylation is dependent on the Snf2H dependent
remodelling activity, as Snf2H-K211R, the ATPase
mutant that cannot move nucleosomes any more, fails to
increase the DNA methylation levels.
To test for differences in Dnmt3a binding to the
non-remodelled and remodelled substrates we performed
Figure 4. Chromatin remodelling stimulates de novo DNA methylation. (A) Chromatin remodelling reactions were performed in the presence of WT
Snf2H (lanes 3–5) or mutant Snf2H K211R (lanes 6 and 7) using a 0.7–1.5 molar ratio (+, + +) relative to the nucleosomal N78-NPS2-N79 DNA.
Reactions were supplied with ATP or ATPgS as indicated and stopped by the addition of competitor DNA. Nucleosome positions were analysed by
native PAGE. Arrows (ﬁlled inverted triangle) indicate CpG sites on the DNA fragment. Black triangles indicate CpG sites and the oval indicates the
position of the nucleosome. (B) Remodelling reactions were performed as indicated using either nucleosomal (dark grey bars) or free DNA (light grey
bars). DNA methylation with the indicated enzymes was performed for 10min. The incorporation of
3H-methyl groups was measured and the
relative methylation activity (normalized to free DNA) of free DNA and nucleosomes was plotted. Black bars mark the reactions on the remodelled
substrates. Black triangles indicate CpG sites and the oval indicates the position of the nucleosome. (C) Competitive nucleosome-Dnmt3a EMSA.
Either the remodelled nucleosomal template or an equimolar mixture of remodelled and non-remodelled nucleosomes were incubated with a 3.5- to
15-fold molar excess of Dnmt3a (lanes 3–5 and 7–9). Reactions were analysed by native polyacrylamide gel electrophoresis next to a molecular
weight marker (lane 1). Black triangles indicate CpG sites and the oval indicates the position of the nucleosome.
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remodelled and non-remodelled nucleosomes at equimolar
ratios and incubated them with increasing amounts of
Dnmt3a (Figure 4C, Supplementary Figure S6).
In contrast to the preferential binding of symmetric over
asymmetric nucleosomes by Dnmt3a (Figure 1D),
Dnmt3a did not reveal preferential binding to the symmet-
ric nucleosome over the remodelled nucleosome. The
afﬁnity of Dnmt3a was signiﬁcantly increased to the
remodelled nucleosome, suggesting to play a role
in increasing the DNA methylation rates. An additional
explanation for the higher nucleosomal DNA methylation
rates comes from the Peter Jones laboratory, suggesting
that Dnmt3a does preferentially bind to nucleosomes
containing methylated DNA (44). Dnmt3b was shown to
interact with Snf2H in vivo (23), however, we can exclude
a direct stimulatory effect of the remodeller as competitor
DNA disrupted nucleosome-remodeller interactions
(Supplementary Figure S6B). In addition, Snf2H was
used in a 4-fold lower molar ratio compared to Dnmt3a
and Dnmt3b2 and Snf2H binding would have been
visible in the competitive EMSAs.
Nucleosomal DNA is devoid of DNA methylation in vivo
Current studies on the sites and levels of cellular DNA
methylation make use of the free genomic DNA,
ignoring its chromatin organization. We established a
protocol to directly quantify the extent of nucleosomal
and linker DNA methylation, relative to absolute
nucleosome positions in vivo. In order to determine the
chromatin-dependent levels of DNA methylation, we
puriﬁed nucleosomal DNA from HeLa cells. HeLa
chromatin was partially hydrolysed with MNase and the
DNA was puriﬁed. The resulting nucleosomal ladder
exhibited a deﬁned size distribution of DNA fragments,
ranging from mono- to tetranucleosomal sizes (Figure 5A,
lane 2). At high MNase concentrations the
mononucleosomal DNA corresponds to the core-
nucleosomal DNA lacking associated DNA-linkers.
Accordingly, the isolated nucleosomal-core DNA corres-
ponds to  150bp in length (data not shown). The corres-
ponding mono-, di- and trinucleosomal DNA fragments
were puriﬁed (Figure 5A, lanes 3–5) and used for the sub-
sequent quantiﬁcation of DNA methylation levels with an
enzyme-linked assay (Figure 5B). Interestingly, as seen for
the in vitro DNA methylation assays (Figures 2 and 3) we
see a low level of DNA methylation of the nucleosomal
DNA (mononucleosomes) that increases only slightly with
increasing DNA concentration (25–200ng). In contrast,
trinucleosomal DNA, harbouring two accessible linker
regions, exhibits much stronger DNA methylation levels.
This stunning result suggests that DNA methylation is
rather depleted within the nucleosomal DNA and exists
preferentially in the linker region in between the nucleo-
somes. Our data suggest that on a global scale nucleo-
somes are major obstacles for DNA methylation in vivo.
Comparison of 1n, 2n, 3n nucleosomal DNA revealed a
gradual increase in CpG methylation with nucleosomal
repeat length, reﬂecting the relative fraction of DNA
linkers present in the substrate (Figure 5B). To exclude
possible effects of DNA length on the assay readout and
to prove quantiﬁcation, we generated a methylated and
a non-methylated control DNA of 150bp length
(NPS2; Supplementary Figure S5A), showing robust
quantiﬁcation of the data by the enzyme-linked assay
(Figure 5B).
Reduced nucleosomal DNA methylation levels were
also not a result of reduced CpG levels in the nucleosomal
core, as revealed by a re-methylation assay. We compared
the in vitro methylation activity of M.SssI on soniﬁed
genomic DNA of nucleosomal size and the puriﬁed
mononucleosomal DNA (Supplementary Figure S5B).
The result clearly shows a similar number of potential
methylatable sites, arguing against the absence of CpG
dinucleotides within nucleosomes.
To verify the results obtained with the ELISA assay we
quantiﬁed nucleosomal and DNA linker methylation with
an independent method. Mononucleosomal and genomic
DNA 5-methyl cytosine (5-meC) content was quantiﬁed
using micellar capillary electrophoresis (Figure 5C)
according to established protocols (37). With this
method molecules are separated on the basis of differences
in size, charge, structure and hydrophobicity at high
voltages. Gel puriﬁed genomic DNA and mono-
nucleosomal DNA were hydrolysed to nucleosides using
P1 nuclease and antarctic phosphatase and separated by
micellar capillary electrophoresis. The area values of
5-meC and Cytosine were calculated with the carat-
software of the Beckman capillary electrophoresis system.
As a result of 10 independent runs, using different DNA
batches, mononucleosomal DNA and total genomic DNA
exhibited 1.95% (±0.12%) and 3.06% (±0.7%) of 5-meC
levels, respectively. The reduced DNA methylation levels
of nucleosomal DNA are highly signiﬁcant as revealed by
a paired t-test (3.1
 12) and conﬁrm the results of the
ELISA assay. The measured levels of 5-meC in HeLa
genomic DNA corresponds very well to the literature
values (37), conﬁrming the quantitative robustness of
this method. The obtained values allow us to estimate
global DNA methylation levels in nucleosomal versus
linker DNA. The relative 5-meC content of linker and
nucleosomal DNA was determined considering an
average nucleosomal repeat length of 188bp in HeLa
cells (38) and a nucleosomal DNA length of 147bp. We
also considered an equal distribution of CpG dinucleo-
tides along the DNA, neglecting the 6.8% CpG sites
within CpG islands (45). The total of methylated CpG
sites was calculated as the percentage of the proportion
of linker DNA added to the proportion of nucleosomal
DNA multiplied with the relative nucleosomal 5-meC
content. According to these assumptions we calculated
a 2-fold higher methylation level of the linker DNA
compared to the nucleosomal DNA (Figure 5D).
DISCUSSION
In this study we examined the binding characteristics of
Dnmt3a and Dnmt3b2 towards mononucleosomes
exhibiting DNA linkers of varying length, the de novo
DNA methylation of nucleosomes in vitro and the effect
Nucleic Acids Research, 2011,Vol.39, No. 16 6965Figure 5. Nucleosomal DNA is devoid of CpG methylation in vivo. (A) Chromatin from HeLa cells was partially hydrolysed with MNase (lanes 1
and 2) and the puriﬁed DNA was analysed by agarose gel electrophoresis. The nucleosome-sized DNA fragments are indicated on the right. Mono-,
di- and tri-nucleosomal (1n, 2n, 3n) DNA was isolated and analysed (lanes 3–5). Molecular weight marker (M) and DNA sizes are indicated.
(B) DNA methylation levels for mononucleosomal (white bars) and trinucleosomal (black bars) DNA using increasing DNA amounts, was
determined with a meCpG-sensitive ELISA assay (Sigma). A comparative DNA methylation analysis for 100ng of different nucleosomal DNAs
(1n, 2n, 3n), methylated control DNA (ctrl mDNA), non-methylated and methylated NPS2 DNA (mNPS2) is shown. (C) Micellar capillary
electrophoresis of nucleosides ( 4mg/ml) from puriﬁed and hydrolysed mononucleosomal DNA (left) and genomic HeLa DNA (right). The absorb-
ance (AU) is plotted against the migration time (t; min). The peaks for 20-deoxycytidine (C), 5-methyl 20-deoxycytidine (5-meC) and an impurity
(asteriks) are indicated. (D) The average (n=10) of the 5-meC content of mononucleosomal (light grey) and Hela genomic DNA (dark grey) was
calculated as percentage of (Area 5-meC/(Area C+Area 5-meC). Statistical signiﬁcance of the data was calculated using the paired t-test. The
calculated 5-meC content of mononucleosomal DNA (light grey, 147bp) relative to the 5-meC content of linker DNA (dark grey, 41bp) is given in
the graph on the right.
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DNA methylation. As an advancement to previous studies
and important for our detailed analysis, we established
protocols to purify highly active recombinant Dnmt3a
and Dnmt3b2 free of endogenous DNA (Figure 1A) and
prepared high-quality mononucleosomes using the salt
dialysis method (Figure 2A, Supplementary Figures S3A
and S6A). The bacterial CpG-speciﬁc DNA
methyltransferase M.SssI served as a crucial internal
control that allowed us to assess positioning of our
nucleosomes and the level of contaminating free DNA in
the reaction. Essentially, M.SssI-dependent DNA
methylation is inhibited by the DNA bound histone
octamer (41).
In agreement with previous ﬁndings, EMSAs
(Figure 1D, Supplementary Figure S2A and B) revealed
that Dnmt3a bound to free DNA and nucleosomes with
short linker DNA with similar afﬁnity (21,32). However,
we clearly demonstrate preferential binding of Dnmt3a to
the mononucleosome 77-NPS1-77, showing that Dnmt3a
is able to recognize speciﬁc nucleosomal structures.
In contrast, Dnmt3b2 showed similar afﬁnities towards
DNA and mononucleosomes with long linker DNA
(i.e. 77-NPS1-77). The DNA is the preferred substrate,
as symmetric and asymmetric nucleosomes and nucleo-
somes without DNA overhangs are bound in a hierarchic
order (Figure 1D, Supplementary Figure S2A and B).
Recently, the ADD-domains of Dnmt3a and Dnmt3b
were shown to bind similar well to the non-modiﬁed
histone H3 tail (42), however, we show that the DNA
linkers present a much better substrate for the enzymes
(Figure 1D, Supplementary Figure S2A–C). The import-
ance of linker DNA binding was also shown by
Takeshima and co-workers, showing the modulation of
Dnmt3a binding to the DNA linkers by histone H1 (33).
Different binding characteristics of Dnmt3a and Dnmt3b2
towards DNA and nucleosomes are probably reﬂected by
differences in the DNA interacting domains. Next to the
catalytic domain, the PWWP-domain was shown to bind
to DNA. The PWWP-domain of Dnmt3b showed higher
DNA binding afﬁnities than Dnmt3a (46), consistent
with a lower KM-value of Dnmt3b for free DNA (26).
These results do support our ﬁndings in that DNA is the
preferred substrate for Dnmt3b2. However, besides
the characterized PWWP-domain other regions of the
proteins may be involved in the modulation of the nucleo-
somal binding properties.
With our elaborate in vitro analysis of nucleosomal
DNA methylation by means of incorporation of
3H-methyl groups into the DNA (Figure 2B and C) or
bisulﬁte treatment of methylated DNA (Figure 3), we
are now able to reveal a precise picture of de novo DNA
methylation in chromatin. Free DNA overhangs were
preferentially methylated (Figure 3A), whereas DNA
methylation of Dnmt3a and Dnmt3b2 within the region
of the nucleosome was strongly reduced to 2.8–3.7% of
the CpG levels (Figure 3A and B). An inhibitory effect of
the nucleosomal structure on DNA methylation has been
shown for Dnmt3a and Dnmt3b2 (21,32,33), however, our
results show a much higher protection by the nucleosome
as previously reported. Experiments showing similar
Dnmt3a-dependent methylation efﬁciency of free DNA
and mononucleosomes are probably the result of DNA
contaminations within the enzyme preparations (30).
In contrast to our results, Takeshima and colleagues
observed signiﬁcant nucleosomal DNA methylation with
Dnmt3b and M.SssI (32). Considering the enzymatic
properties of M.SssI (41) and the high afﬁnity of
Dnmt3b for naked DNA (26) it is rather tempting to
speculate that nucleosomal preparations were not
fully reconstituted and still contained free DNA in the
reaction.
A recent study applying similar approaches showed ef-
ﬁcient de novo methylation of DNA linkers and reduced
levels of nucleosomal DNA methylation spreading
throughout the nucleosome (42). As the authors did not
include a M.SssI control it could be that low levels of free
DNA were present in the reaction. Most strikingly, our
analysis demonstrates that the low-level nucleosomal
DNA methylation of Dnmt3a and Dnmt3b2 was limited
to the entry/exit sites of the nucleosome and did not
spread along the entire nucleosomal region.
The functional correlation of ATP-dependent chroma-
tin remodelling enzymes and DNA methylation in vivo has
been described (47). In particular, Lsh, a member of the
SNF2 superfamily of helicases, was shown to be essential
for genome-wide DNA methylation (14) and to inﬂuence
de novo DNA methylation levels (15), through recruitment
of Dnmt3b (16,17,48). Similarly, we observe that chroma-
tin remodelling activity is required to generate DNA
access and to allow nucleosomal DNA methylation
(Figure 4). However, the Dnmt3a DNA methylation efﬁ-
ciency was increased almost 2-fold on the repositioned
nucleosome, resulting in a DNA methylation efﬁciency
superior to free DNA. This result suggests that the
remodelled nucleosome presents a specialized substrate,
stimulating the activity of Dnmt3a.
Indeed, we were able to show that Dnmt3a exhibits a
relatively higher afﬁnity to the remodelled nucleosome as
to asymmetric positioned nucleosomes. The higher afﬁnity
towards the remodelled nucleosome and the fact that
Dnmt3a binds with higher afﬁnity to methylated nucleo-
somal DNA may explain the elevated DNA methylation
levels in remodelled nucleosomes (44). Augmented DNA
methylation may be in part a result of a particular chro-
matin structure established by the remodelling enzyme,
which is recognized as a preferential substrate by the
DNA methyltransferases. With respect to the data of the
Jones laboratory, we suggest that the initial methylation
of the remodelled nucleosome converts it into a high
afﬁnity substrate that is even methylated better than free
DNA. Differential substrate binding features and the
higher activity of Dnmt3a for remodelled nucleosomes
may hint to functional differences and distinct localiza-
tions of the methyl transferases, depending on the chro-
matin structure in the cell. Future experiments will address
the mechanism of efﬁcient nucleosomal DNA methylation
in kinetically resolved assay systems.
For the ﬁrst time, we directly quantiﬁed the levels of
nucleosomal DNA methylation in vivo. By the isolation
of nucleosomal core fragments, we were able to quantify
the different levels of DNA methylation between
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enzyme-linked assay indicated strong differences in
DNA methylation levels, only the micellar capillary elec-
trophoresis system was suitable to provide a quantitative
measure. The global maintenance of a 2-fold difference in
nucleosomal versus linker DNA methylation levels gives
important insights into the dynamics of chromatin struc-
ture in vivo and the mechanisms of DNA methylation. As
we have shown, the nucleosome is refractory to DNA
methylation, and ATP-dependent chromatin dynamics is
required to circumvent nucleosomal inaccessibility. Low
levels of nucleosomal DNA methylation in vivo suggest a
rather non-dynamic chromatin structure in the cell, with
nucleosomes occupying the same sites throughout the cell
cycle. Indicating that the activity of the numerous chro-
matin remodelling machines is highly restricted and
maintain speciﬁc chromatin structures (12,49), rather
than creating ﬂuid chromatin structures that are accessible
to any kind of DNA modiﬁcation. Our analysis gives
insights on the distribution of DNA methylation on a
global scale. We suggest that local DNA methylation
patterns, especially at regulatory regions, may escape
this rule of nucleosomal depletion, as active chromatin
remodelling occurs at these sites.
The nucleosome position-dependent distribution of
DNA methylation could not be detected by the
methylome mapping studies, as global nucleosome pos-
itioning varies from cell to cell (50). Nucleosome spacing
is comparable from cell to cell, but the actual positions are
not the same relative to the underlying DNA.
High-throughput sequencing approaches to evaluate the
DNA methylome, have only generated short sequence
reads, that do not resolve nucleosome positioning
features (51,52). These assays were not designed to
observe the chromatin structure dependent DNA methy-
lation patterns. High-resolution, chromatin-dependent
DNA methylation maps will be required to dissect the
global and local effects of chromatin structure on the
epigenome. In contrast to a recent study showing a very
modest increase of 1.2% (from 75% to 76.2%) of nucleo-
somal DNA methylation compared to the linker DNA
(53), we observed a 2-fold decrease of DNA methylation
levels within the nucleosome core particles. The discrep-
ancy arises from the used methodology. Whereas we did
directly quantify DNA methylation levels, Pellegrini and
coworkers performed a correlation analysis between
nucleosome positions and known DNA methylation
maps (53). Their analysis ignores the fact that most
nucleosome positions vary from cell to cell and that
DNA methylation maps represent a summary of DNA
methylation sites of multiple cells.
In summary, we show that chromatin structure does
inﬂuence de novo DNA methylation in vitro and in vivo,
targeting global DNA methylation to the linker regions of
the nucleosomes. This indicates that besides the high levels
of remodelling enzymes in the cell, the global chromatin
structure in vivo is not ﬂuid. We hypothesize that DNA
methylation is only actively changed at regulatory sites
where differential recruitment of remodelling enzymes
actively changes the chromatin structure and DNA
accessibility.
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